Compare Marvell Technology Inc (MRVL) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marvell Technology Inc vs Twist Bioscience Corp — how do they compare? Marvell Technology Inc trades at $209.85 (market cap $171.11B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Marvell Technology Inc is far larger — about 31.4× Twist Bioscience Corp's market cap, and Marvell Technology Inc pays a 0.12% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| MRVL | TWST | |
|---|---|---|
Market Cap | $171.11B | $5.45B |
Sector | Technology | Health |
52-Week High | $316.43 | $102.88 |
52-Week Low | $62.31 | $24.16 |
Enterprise Value | $172.55B | $5.37B |
Dividend Yield | 0.12% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marvell Technology Inc
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
